Evidence map›Paper›PMID 38748853›Full record

ArticleMagnetic resonance in medicine2024

Whole-cerebrum guanidino and amide CEST mapping at 3 T by a 3D stack-of-spirals gradient echo acquisition.

Kexin Wang, Licheng Ju, Yulu Song, Lindsay Blair, Kevin Xie, Claire Liu, Anna M Li, Dan Zhu, Feng Xu, Guanshu Liu and 7 more

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Rapid 3D whole-brain high-resolution TMagnetic resonance in medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kexin WangF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.ORCID 0000-0003-0124-0631
Licheng JuF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Yulu SongRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Lindsay BlairThe Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Kevin XieF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Claire LiuF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Anna M LiF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Dan ZhuF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.ORCID 0000-0002-0940-1519
Feng XuF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.ORCID 0000-0001-7958-3787
Guanshu LiuF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Hye-Young HeoF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.ORCID 0000-0002-7297-2015
Nirbhay Narayan YadavF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Georg OeltzschnerF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.ORCID 0000-0003-3083-9811
Richard A E EddenF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Qin QinF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.ORCID 0000-0002-6432-2944
David Olayinka KamsonThe Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Jiadi XuF. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.ORCID 0000-0001-9698-5622

Funding

TRD 4: Platforms for multi-modal and multi-scale imaging dataP41EB031771 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Hanzhang Lu, Peter CM Van Zijl · 2021 to 2026
$9.9M
IN VIVO MURINE CARDIAC ENERGY METABOLISM AND FUNCTIONR01HL063030 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI WEISS, ROBERT G · 2000 to 2018
$4.9M
Cerebrospinal fluid exchange in Alzheimer's disease characterized by advanced MRI techniquesR01AG080104 · NIA · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI JIadi Xu · 2023 to 2026
$2.9M
MRI based phosphocreatine mapping method to assess patients with peripheral arterial disease.R01HL149742 · NHLBI · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Michael Schaer, JIadi Xu · 2020 to 2026
$2.5M
Altered pH in early Alzheimer's disease detected by creatine chemical exchange saturation transfer MRIR21AG074978 · NIA · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI XU, JIADI · 2022 to 2022
$444k
NHLBI NIH HHS R01 HL063030NHLBI NIH HHS R01 HL149742NIA NIH HHS R01 AG080104NIA NIH HHS R21 AG074978NIBIB NIH HHS P41 EB031771NIH HHS P41EB031771NIH HHS R01AG080104NIH HHS R01HL149742NIH HHS R21AG074978
6 · The paper itself

Abstract

purposeTo develop a 3D, high-sensitivity CEST mapping technique based on the 3D stack-of-spirals (SOS) gradient echo readout, the proposed approach was compared with conventional acquisition techniques and evaluated for its efficacy in concurrently mapping of guanidino (Guan) and amide CEST in human brain at 3 T, leveraging the polynomial Lorentzian line-shape fitting (PLOF) method.

methodsSaturation time and recovery delay were optimized to achieve maximum CEST time efficiency. The 3DSOS method was compared with segmented 3D EPI (3DEPI), turbo spin echo, and gradient- and spin-echo techniques. Image quality, temporal SNR (tSNR), and test-retest reliability were assessed. Maps of Guan and amide CEST derived from 3DSOS were demonstrated on a low-grade glioma patient.

resultsThe optimized recovery delay/saturation time was determined to be 1.4/2 s for Guan and amide CEST. In addition to nearly doubling the slice number, the gradient echo techniques also outperformed spin echo sequences in tSNR: 3DEPI (193.8 ± 6.6), 3DSOS (173.9 ± 5.6), and GRASE (141.0 ± 2.7). 3DSOS, compared with 3DEPI, demonstrated comparable GuanCEST signal in gray matter (GM) (3DSOS: [2.14%-2.59%] vs. 3DEPI: [2.15%-2.61%]), and white matter (WM) (3DSOS: [1.49%-2.11%] vs. 3DEPI: [1.64%-2.09%]). 3DSOS also achieves significantly higher amideCEST in both GM (3DSOS: [2.29%-3.00%] vs. 3DEPI: [2.06%-2.92%]) and WM (3DSOS: [2.23%-2.66%] vs. 3DEPI: [1.95%-2.57%]). 3DSOS outperforms 3DEPI in terms of scan-rescan reliability (correlation coefficient: 3DSOS: 0.58-0.96 vs. 3DEPI: -0.02 to 0.75) and robustness to motion as well.

conclusionThe 3DSOS CEST technique shows promise for whole-cerebrum CEST imaging, offering uniform contrast and robustness against motion artifacts.

Indexed as

AmidesBrainImaging, Three-DimensionalMagnetic Resonance ImagingAdultAlgorithmsBrain NeoplasmsEcho-Planar ImagingFemaleGliomaGuanidineHumansImage Processing, Computer-AssistedMaleReproducibility of ResultsSignal-To-Noise RatioAmidesGuanidine3D stack‐of‐spirals GRE (3DSOS)amideCESTarginine CEST (ArgCEST)chemical exchange saturation transfer (CEST)concentrationcontinuous wave gradient‐ and spin‐echo (cwGRASE)creatine CEST (CrCEST)exchange rateguanidino or guanidinium CEST (GuanCEST)high spectral resolution (HSR) CESTpolynomial Lorentzian line‐shape fitting (PLOF)segmented 3D EPI (3DEPI)

Identifiers

PMID38748853
PMCPMC11262991

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.